Methocarbamol Micro Pellets MUPS
Methocarbamol is marketed under different names when presented in combination with other active ingredients. In combination with acetaminophen (Paracetamol), its trade name is Robaxacet, whereas Robax Platinum is the trade name for a formulation of methocarbamol and ibuprofen. A combination of methocarbamol and aspirin is marketed as Robaxisal.
Unlike other carbamates such as carisoprodol and meprobamate, Methocarbamol has greatly reduced abuse potential. Studies comparing it to lorazepam (Ativan) and diphenhydramine (Benedryl), along with placebo, find that methocarbamol produces increased 'liking' responses and some sedative-like effects, however, at higher doses dysphoria is reported. It is considered to have an abuse profile similar to, but weaker than, lorazepam.
Potential side-effects include: drowsiness, dizziness, upset stomach, flushing, blurred vision, and fever. Serious side-effects include the development of a severe skin rash or itching, slow heart rate, fainting, jaundice, persistent nausea/vomiting, stomach/abdominal pain, mental/mood changes, clumsiness, trouble urinating, signs of infection. In addition, methocarbamol may cause urine to turn black, blue, or green. However, this effect is harmless.
Methocarbamol Micro Pellets - Multiple Unit Particle System (MUPS)
Methocarbamol Micro Granules - Multiple Unit Particle System (MUPS)